|
⚲
|
| Keyboard |
| Maged Shenouda | |
|---|---|
| Firm | |
| Address | 880 Third Avenue 12th Floor New York, NY 10022 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Relmada Therapeutics Inc | 021-350641 | Director | 0.8 M of 0.8 M |
||
| Relmada Therapeutics Inc | 021-343016 | Director | 8.4 M of 10.0 M |
||
| Relmada Therapeutics Inc | 021-339798 | Director | 3.4 M of 10.0 M |
||
| Azurrx Biopharma Inc | 021-333838 | Executive Officer | 2.0 M of 2.0 M |
||
| Relmada Therapeutics Inc | 021-324029 | Director | 5.8 M of 10.0 M |
||
| Relmada Therapeutics Inc | 021-296142 | Director | 6.9 M of 6.9 M |
||
| Azurrx Biopharma Inc | 021-288822 | Director | 5.0 M of 5.0 M |
||
| Azurrx Biopharma Inc | 021-285301 | Director | 1.0 M of 1.0 M |
||
| Protea Biosciences Group Inc | 021-274750 | Director | 0.6 M of 5.0 M |
||
| Protea Biosciences Group Inc | 021-264445 | Director | 0.7 M of 2.5 M |
||
| Azurrx Biopharma Inc | 021-261048 | Director | 0.6 M of 12.0 M |
||
| Protea Biosciences Group Inc | 021-247477 | Director | 0.5 M of 4.0 M |
||
| Protea Biosciences Group Inc | 021-241248 | Director | 2.0 M of 2.0 M |
||